arrow
H

Heinz-Peter Schlemmer

Helmholtz Association
H指数:47
被引数:8,609

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Baseline dual-energy CT iodine uptake predicts systemic but not lesion-level progression in immunotherapy-treated metastatic melanoma

基线双能量CT碘摄取预测免疫治疗转移性黑色素瘤的系统进展而非病灶级进展

2026-08-010
OAAI
IDH status shapes glioma oncotopy: voxel-wise mapping of 644 adult diffuse gliomas

IDH状态塑造胶质瘤的肿瘤空间分布:644例成人弥漫性胶质瘤的体素级映射

2026-06-010
OA
HyperSightTM-CBCT based monitoring of sarcopenia during definitive radiotherapy of prostate cancer: a longitudinal feasibility study

基于HyperSightTM-CBCT的肌肉减少症监测在前列腺癌根治性放射治疗期间的应用:一项纵向可行性研究

2026-05-290
OAAI
Risk-adapted Prostate Cancer Screening Achieves Mammography-like Benefits: Evidence and Implications for Europe

风险适应型前列腺癌筛查实现了类似乳腺X光的效益:证据及其对欧洲的影响

2025-12-180
PRE
Validation of novel low-dose CT methods for quantifying bone marrow in the appendicular skeleton of patients with multiple myeloma: initial results from the [18F]FDG PET/CT sub-study of the Phase 3 GMMG-HD7 Trial

验证用于量化多发性骨髓瘤患者四肢骨骼骨髓的新型低剂量CT方法:来自Phase 3 GMMG-HD7试验[18F]FDG PET/CT亚研究的初步结果

2025-10-010
OA
Do We Need Early Detection of Grade Group 2 Prostate Cancer in a Screening Program for Young Men? Results from the PROBASE Screening Trial

我们是否需要在针对年轻男性的筛查计划中早期检测Gleason评分组2的前列腺癌?PROBASE筛查试验的结果

2025-07-100
OAAI
Automated Detection of Focal Bone Marrow Lesions From MRI: A Multi-center Feasibility Study in Patients with Monoclonal Plasma Cell Disorders

基于MRI的局灶性骨髓病变自动检测:一项在单克隆浆细胞疾病患者中的多中心可行性研究

2025-07-090
OAAI
Prostate Cancer Detection in Younger Men: A Comparative Analysis of Systematic and Magnetic Resonance Imaging–targeted Biopsy in the PROBASE Trial

年轻男性前列腺癌检测:系统活检与磁共振成像靶向活检的比较分析——PROBASE试验

2025-06-020
OAAI
Characterisation of Multiparametric Magnetic Resonance Imaging of the Prostate in Younger Men with Normal Prostate-specific Antigen Within the PROBASE Study

前列腺多参数磁共振成像在PROBASE研究中的特征分析:年轻且前列腺特异性抗原正常男性群体

2025-05-010
PRE
Empowering cancer research in Europe: the EUCAIM cancer imaging infrastructure
2025-02-240
OAAI
Prospective planning comparison of magnetic resonance-guided vs. internal target volume-based stereotactic body radiotherapy of hepatic metastases - Which patients do really benefit from an MR-linac?

前瞻性规划比较:磁共振引导与基于内靶区体积的肝转移灶立体定向体部放射治疗——哪些患者真正能从MR- linac中获益?

2025-02-010
OAAI
Risk-adjusted Screening for Prostate Cancer-Defining the Low-risk Group by Data from the PROBASE Trial

风险调整后的前列腺癌筛查—利用PROBASE试验数据定义低风险组

2024-12-010
OAAI